VC firms
NewVale Capital is a growth equity firm investing in proven life science services and enabling technologies for healthcare.
Funds raised 1
| Date | Fund size | Announcement |
| Sign up to see | Sign up to see | Sign up to see |
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 10, 2025 | Noxilizer Raises $30M in Funding | Noxilizer, a Hanover, MD-based company which specializes in nitrogen dioxide-based terminal sterilization for biopharmaceutical and medical device products, raised $30M in funding. The round was led by NewVale Capital. The company intends t... |
| May 13, 2024 | Business | Boulder-based NewVale Capital closes first fund with $167M to invest in life-sciences space | |
| May 13, 2024 | NewVale Capital wraps up debut fund at $167m |
Reviews 0
FAQ about NewVale Capital
What funds has NewVale Capital raised?
NewVale Capital has announced 1 fund on Parsers VC.
How many startups has NewVale Capital invested in?
NewVale Capital has 1 portfolio company on Parsers VC.
What has the press written about NewVale Capital?
Parsers VC has collected 4 articles mentioning NewVale Capital, among them “Noxilizer Raises $30M in Funding” (Sep 10, 2025) and “Business | Boulder-based NewVale Capital closes first fund with $167M to invest in life-sciences space” (May 13, 2024).
Is NewVale Capital still active?
Yes, NewVale Capital is active; its latest activity on Parsers VC dates from Jul 2, 2026.